Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1ГБОУ ВПО Северо-Западный государственный медицинский университет им. И.И.Мечникова Минздрава России. 191015, Россия, Санкт-Петербург, ул. Кирочная, д. 41; 2Санкт-Петербургское государственное бюджетное учреждение Психоневрологический диспансер №9. 192131, Россия, Санкт-Петербург, ул. Ивановская, д. 18
A.G.Sofronov1, A.A.Spikina1, O.V.Rylskaia2 1 I.I.Mechnikov State Northwestern Medical University of the Ministry of Health of the Russian Federation. 191015, Russian Federation, Saint Petersburg, ul. Kirochnaia, d. 41; 2 Psychoneurological State Dispensary №9 192131, Russian Federation, Saint Petersburg, ul. Ivanovskaia, d. 18
Список исп. литературыСкрыть список 1. Авруцкий Г.Я., Гурович И.Я., Громова В.В. Фармакотерапия психических заболеваний. М.: Медицина, 1974; с. 470. / Avrutskii G.Ia., Gurovich I.Ia., Gromova V.V. Farmakoterapiia psikhicheskikh zabolevanii. M.: Meditsina, 1974; s. 470. [in Russian] 2. Абрамова Л.И., Новоженова Т.Е., Сорокин С.А. Вальдоксан (агомелатин): современный подход к лечению умеренных и тяжелых эндогенных депрессий непсихотического уровня. Обозрение психиатрии и медицинской психологии. 2011; 3. / Abramova L.I., Novozhenova T.E., Sorokin S.A. Val'doksan (agomelatin): sovremennyi podkhod k lecheniiu umerennykh i tiazhelykh endogennykh depressii nepsikhoticheskogo urovnia. Obozrenie psikhiatrii i meditsinskoi psikhologii. 2011; 3. [in Russian] 3. Воробьева О.В. Вальдоксан в терапии депрессии в неврологической практике: результаты российского многоцентрового натуралистического исследования «Резонанс». Журн. неврологии и психиатрии. 2012; 9. / Vorob'eva O.V. Val'doksan v terapii depressii v nevrologicheskoi praktike: rezul'taty rossiiskogo mnogotsentrovogo naturalisticheskogo issledovaniia «Rezonans». Zhurn. nevrologii i psikhiatrii. 2012; 9. [in Russian] 4. Мазо Г.Э. Влияние депрессии на течение шизофрении. Материалы юбилейной научной сессии «Психоневрология в современном мире». СПб., 2007; с. 106. / Mazo G.E. Vliianie depressii na techenie shizofrenii. Materialy iubileinoi nauchnoi sessii «Psikhonevrologiia v sovremennom mire». SPb., 2007; s. 106. [in Russian] 5. Нуллер Ю.Л. Депрессия и деперсонализация. Л.: Медицина, 1981. / Nuller Iu.L. Depressiia i depersonalizatsiia. L.: Meditsina, 1981. [in Russian] 6. Смулевич А.Б. Депрессии при соматических и психических заболеваниях. М.: Медицинское информационное агентство, 2003. / Smulevich A.B. Depressii pri somaticheskikh i psikhicheskikh zabolevaniiakh. M.: Meditsinskoe informatsionnoe agentstvo, 2003. [in Russian] 7. Тиганов А.С. Руководство по психиатрии: В 2 т. Т. 1. М.: Медицина, 1999. / Tiganov A.S. Rukovodstvo po psikhiatrii: V 2 t. T. 1. M.: Meditsina, 1999. [in Russian] 8. Addington D, Addington J, Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry (Suppl.) 1993; 22: 39–44. 9. Samsom JN, Albert HC Wong. Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models. Front Psychiatry 2015; 6: 13. 10. Buckley PF, Miller BJ, Lehrer DS, Castle DJ. Psychiatric Comorbidities and Schizophrenia. Schizophr Bull 2009; 35 (2): 383–402. 11. Häfner H, Maurer K, An der Heiden W. Schizophrenia – a disorder in its own right? Results from 25 years of the ABC study. Nervenarzt 2013; 84 (9): 1093–4, 1096–103. 12. Sönmez N, Romm KL, Andreasssen OA et al. Depressive symptoms in first episode psychosis: a one-year follow-up study. BMC Psychiatry (2013) 13:106.10.1186/1471-244X-13-106. 13. McGlashan T, Carpenter WT., Jr Postpsychotic depression in schizophrenia. Arch Gen Psychiatry 1976; 33: 231–910. 14. Upthegrove R, Birchwood M, Ross K, Brunett K, McCollum R, Jones L. The evolution of depression and suicidality in first episode psychosis. Acta Psychiatr Scand. 2010 Sep; 122(3): 211–8. 15. Andriopoulos I, Ellul J, Skokou M, Beratis S. Suicidality in the "prodromal" phase of schizophrenia. Compr Psychiatry. 2011 Sep-Oct; 52 (5): 479–85. 16. Gozdzik-Zelazny A, Borecki L, Pokorski M. Depressive symptoms in schizophrenic patients. Eur J Med Res 2011; 16 (12): 549–52. 17. Möller HJ. Bipolar disorder and schizophrenia: distinct illnesses or a continuum? J Clin Psychiatry 2003; 64 (Suppl. 6): 23–7. 18. Bartels SJ, Drake RE. Depressive symptoms in schizophrenia: comprehensive differential diagnosis. Compr Psychiatry 1988; 29 (5): 467–83. 19. Roth S. The seemingly ubiquitous depression following acute schizophrenic episodes, a neglected area of clinical discussion. Am J Psychiatry 1970; 127(1): 51–8. 20. Herz M. Prodromal symptoms and prevention of relapse in schizophrenia. J Clin Psychiatry 1985; 46 (11 Pt 2): 22–5. 21. Johnson DA. The significance of depression in the prediction of relapse in chronic schizophrenia. Br J Psychiatry 1988; 152: 320–3. 22. Tsuang D, Coryell W. An 8-year follow-up of patients with DSM-III-R psychotic depression, schizoaffective disorder, and schizophrenia. Am J Psychiatry 1993; 150 (8): 1182–8. 23. Siris S, Bench C. Depression and schizophrenia. In: Hirsch S, Weinberger D, editors. Schizophrenia. 2nd ed. Oxford, UK: Blackwell, 2003; p. 142–67. 24. Barch DM, Sheline YI, Csernansky JG, Snyder AZ. Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression. Biol Psychiatry 2003; 53 (5): 376–84. 25. Pokorski M, Warzecha A. Depression and religiosity in older age. Eur J Med Res 2011; 16 (9): 401–6. 26. Barnes TR, Curson DA, Liddle PF, Patel M. The nature and prevalence of depression in chronic schizophrenic in-patients. Br J Psychiatry 1989; 154: 486–91. 27. Sands JR, Harrow M. Depression during the longitudinal course of schizophrenia. Schizophr Bull 1999; 25 (1): 157–71. 28. Müller MJ, Müller K-M, Fellgiebel A. Detection of Depression in Acute Schizophrenia: Sensitivity and Specificity of 2 Standard Observer Rating Scales. Can J Psychiatry 2006; 51 (6). 29. Samuel G. Siris. Treating ‘depression’ in patients with schizophrenia. A thorough differential diagnosis determines the best treatment approach 2012; 11; 8. 30. Bojana Avguštin. Depression in schizophrenia – literature overview. Psychiatria Danubina 2009; 21 (Suppl. 1): 93–7. 31. Kasckow J, Lanouette N, Patterson T et al. Treatment of subsyndromal depressive symptoms in middleaged and older adults with schizophrenia: effect on functioning. Int J Geriatr Psychiatry 2010; 25 (2): 183–90. 32. Felmet K, Zisook S, Kasckow JW. Elderly Patients with Schizophrenia and Depression: Diagnosis and Treatment. Clin Schizophr Relat Psychoses 2011; 4 (4): 239–50. 33. Kasckow JW, Zisook S. Co-Occurring Depressive Symptoms in the Older Patient with Schizophrenia. Drugs Aging 2008; 25 (8): 631–47. 34. Silver H, Nassar A. Fluvoxamine improves negative symptoms in treated chronic schizophrenia: an add-on double-blind, placebo-controlled study. Biol Psychiatry 1992; 31: 698–704. [PubMed: 1599987] 35. Addington D, Addington J, Patten S. Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia. J Clin Psychopharmacol 2002; 22: 20–5. [PubMed: 11799338] 36. Lako IM, Taxis K, Bruggeman R et al. The course of depressive symptoms and prescribing patterns of antidepressants in schizophrenia in a one-year follow-up study. Eur Psychiatry 2012; 27: 240–4. 37. Paul Plasky. Antidepressant Usage in Schizophrenia. Schizophrenia Bulletin1991; 17 (4). 38. Siris SG. Diagnosis of Secondary Depression in Schizophrenia: Implications for DSM-IV. Schizophrenia Bulletin 1991; 17 (1). 39. Sands JR, Harrow M. Depression During the Longitudinal Course of Schizophrenia. Schizophrenia Bulletin 1999; 25 (1): 157–71. 40. Bermanzohn PC, Porto L, Arlou PB et al. At Issue: Hierarchical Diagnosis in Chronic Schizophrenia: A Clinical Study of Co-occurring Syndromes. Schizophrenia Bulletin 2000; 26 (3). 41. Siris SG. Depression in Schizophrenia: Perspective in the Era of "Atypical” Antipsychotic Agents. Am J Psychiatry 2000; 157: 1379–89. 42. Thomas RE Barnes and the Schizophrenia Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology. J Psychopharmacology 2011; p. 1–54. 43. Mulholland C, Cooper S. The symptom of depression in schizophrenia and its management. Advances Psychiatric Treatment 2000; 6: p. 169–77. 44. Mulholland C, Lynch G, King DJ, Cooper SJ. A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia. J Psychopharmacol 2003;17 (1): 107–12.